Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Valencia
Clinical trial register · Spain

Clinical Trials in Valencia, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Madrid 59 Barcelona 57 Valencia 23 Seville 22 L'Hospitalet de Llobregat 19
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Trials with a site in Valencia

23 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Active, closed
Pfizer
Phase 3
1,078
Málaga, Barcelona, Castilleja de la Cuesta, Chiclana de la Frontera, Madrid, Sanlúcar de Barrameda, Seville, Valencia
2026-02-24
Recruiting
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
NCT07227298Advanced/Metastatic Non-Small Cell Lung Cancer, Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Cancer
Pfizer
Phase 1/2
162
Jaén, Barcelona, Jerez de la Frontera, Madrid, Málaga, Valencia, Cadiz, Granada
2026-01-30
Active, closed
Pfizer
Phase 3
3,578
Málaga, Castilleja de la Cuesta, Chiclana de la Frontera, Madrid, Sanlúcar de Barrameda, Seville, Valencia
2025-12-19
Recruiting
Pfizer
Phase 3
800
Santiago de Compostela, Málaga, Barcelona, L'Hospitalet de Llobregat, Jerez de la Frontera, Madrid, Córdoba, Valencia
2025-12-11
Recruiting
Pfizer
Phase 2
200
Santiago de Compostela, Córdoba, Barcelona, Alcorcón, Valencia
2025-10-30
Recruiting
Pfizer
Phase 3
1,000
Barcelona, Madrid, Vigo, Valencia
2025-09-28
Recruiting
Pfizer
Phase 3
714
A Coruña, Elche, Barcelona, L'Hospitalet de Llobregat, Jerez de la Frontera, Palma, Madrid, Valencia
2025-07-23
Active, closed
Pfizer
Phase 1/2
74
Barcelona, Madrid, Málaga, Valencia, Granada
2025-06-30
Recruiting
Pfizer
Phase 2
620
Santiago de Compostela, Barcelona, L'Hospitalet de Llobregat, Majadahonda, Madrid, Valencia
2025-06-19
Active, closed
Pfizer
Phase 3
200
Barcelona, Madrid, Vigo, Seville, Valencia, Valladolid
2024-11-15
Recruiting
Pfizer
Phase 3
900
L'Hospitalet de Llobregat, Madrid, Valencia
2024-10-22
Active, closed
Pfizer
Phase 3
600
L'Hospitalet de Llobregat, Barcelona, Madrid, Manresa, Valencia
2024-10-21
Active, closed
Pfizer
Phase 3
1,571
Córdoba, Badalona, L'Hospitalet de Llobregat, Santiago de Compostela, Madrid, Barcelona, Valencia, Zaragoza
2023-11-08
Recruiting
Pfizer
Phase 4
80
Pamplona, Valencia
2023-10-03
Recruiting
Pfizer
Phase 2
100
Santiago de Compostela, Barcelona, Esplugues de Llobregat, Madrid, El Palmar, Seville, Valencia
2023-05-17
Recruiting
Pfizer
Observational
12,500
L'Hospitalet de Llobregat, Getafe, Leganés, Vigo, Valencia, Barcelona, Madrid, Málaga
2022-10-27
Active, closed
Pfizer
Phase 2
108
Santiago de Compostela, Barcelona, L'Hospitalet de Llobregat, Madrid, Seville, Valencia, Zaragoza
2022-07-11
Recruiting
Pfizer
Phase 3
640
Sabadell, Valladolid, Vigo, Valencia, Madrid, Seville
2022-02-28
Active, closed
Pfizer
Phase 3
841
Santiago de Compostela, Elche, L'Hospitalet de Llobregat, Barcelona, Madrid, Seville, Valencia, Zaragoza
2020-12-21
Active, closed
Pfizer
Phase 3
114
Esplugues de Llobregat, Barcelona, Valencia
2020-11-05
Recruiting
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
NCT03460977Metastatic Castration Resistant Prostate Cancer (mCRPC), Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL)
Pfizer
Phase 1
453
L'Hospitalet de Llobregat, Castellon, Pozuelo de Alarcón, Barcelona, Madrid, Málaga, Valencia
2018-04-17
Rows per page Showing 1–23 of 23
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/valencia

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 23 of those studies with a site in Valencia that also match the filters currently applied.

How many clinical trials are recruiting in Valencia?

13 of the 23 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 10 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Valencia), 23 studies
PhaseStudiesRecruitingShare
Phase 313656.5%
Phase 25321.7%
Phase 1/2218.7%
Observational114.3%
Phase 1114.3%
Phase 4114.3%

Most active sponsors

Lead sponsors with the most studies (Valencia)
Lead sponsorStudiesRecruiting
Pfizer2313
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.